Order Article Reprints

Mpilla G, Aboukameel A, Muqbil I, Kim S, Beydoun R, Philip PA, Mohammad RM, Kamgar M, Shidham V, Senapedis W, et al. PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors. Cancers. 2019; 11(12):1902. https://doi.org/10.3390/cancers11121902

Mpilla, Gabriel, Amro Aboukameel, Irfana Muqbil, Steve Kim, Rafic Beydoun, Philip A. Philip, Ramzi M. Mohammad, Mandana Kamgar, Vinod Shidham, William Senapedis, and et al. 2019. "PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors" Cancers 11, no. 12: 1902. https://doi.org/10.3390/cancers11121902

Mpilla, G., Aboukameel, A., Muqbil, I., Kim, S., Beydoun, R., Philip, P. A., Mohammad, R. M., Kamgar, M., Shidham, V., Senapedis, W., Baloglu, E., Li, J., Dyson, G., Xue, Y., El-Rayes, B., & Azmi, A. S. (2019). PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors. Cancers, 11(12), 1902. https://doi.org/10.3390/cancers11121902